Skip to main content
Signal8

Fresenius Medical Care AG (FMS)

Sector: Services-Misc Health & Allied Services, NEC

Fresenius Medical Care AG logo

Fresenius Medical Care AG

NYSE:FMS
-1.10%$23.40
CLOSED
AH$23.35-0.21%vs close
Mkt Cap$12.15B
Float532.21M
O/S519.02M
VOL1.09M sh
$ Vol$25.44M
RVOL0.78×
Inst Own8.7%
SI0.7%
Div Yield3.69%
Dilution
Fresenius Medical Care AG logoNYSE:FMSClosed$23.40-1.10%
Historical Data
DateOpenHighLowCloseVolume
Nov 6, 202623.1223.5223.1023.401,088,849
Nov 5, 202623.4623.8323.4123.661,471,037
Nov 4, 202622.6723.2422.6223.192,310,299
Nov 3, 202621.5322.0521.4621.732,025,105
Nov 2, 202622.7022.7222.3622.611,462,430
Oct 30, 202622.8222.8922.4522.47967,974
Oct 29, 202622.8923.1322.8423.131,361,108
Oct 28, 202622.4622.7022.4522.62803,024
Oct 27, 202622.5622.6722.4822.50784,325
Oct 26, 202622.7522.9922.7322.75569,774
Oct 23, 202622.4222.7322.2722.68733,459
Oct 22, 202621.5922.2321.5722.231,117,472
Oct 21, 202621.5321.6721.4521.561,257,641
Oct 20, 202622.2322.3220.9121.416,206,349
Oct 19, 202621.8822.0121.8221.94562,844
Oct 16, 202622.2822.3822.1122.17620,939
Oct 15, 202621.9922.2821.8422.131,462,151
Oct 14, 202621.2221.5921.1421.541,214,958
Oct 13, 202621.3721.4221.0521.081,071,393
Oct 12, 202621.2421.3421.1321.21692,123
Analyst Coverage
Analyst Coverage
ConsensusHold
Price Target
Not available
Ratings Distribution
BUY
5
HOLD
13
SELL
2
TOTAL20
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
8.7%
Institutional
(233)
0.0%
Insiderⓘ
(0)
12.9%
5%+ Owners
(1)
78.4%
Unattributed (incl. retail)ⓘ
Institutional8.7%
5%+ Beneficial12.9%
Unattributed (incl. retail)78.4%
Top Shareholders
Sources: 13F, 13D/13GO/S: 519.0M · checked 8 Nov 2026 · market-data provider
Insiders & Institutional Holders
About

Fresenius Medical Care AG & Co. KGaA specializes in comprehensive kidney dialysis treatment and associated services, operating across Germany, North America, and numerous international territories. Through an extensive network of outpatient clinics, it delivers essential dialysis therapy along with laboratory and diagnostic support. For home-based care, the company supplies necessary equipment, provides comprehensive training, and offers ongoing patient assistance, including clinical oversight and coordinating supply deliveries directly to patients. In the United States, Fresenius Medical Care also contracts with hospitals to provide vital dialysis interventions for hospitalized individuals suffering from end-stage renal disease (ESRD) and acute kidney failure. Beyond services, it is a prominent developer, manufacturer, and distributor of a broad range of dialysis products. This portfolio encompasses polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers and solutions, concentrates, bloodlines, renal pharmaceuticals, and water treatment systems.

Additionally, the company produces non-dialysis medical devices, including acute cardiopulmonary and apheresis products.

Its pharmaceutical division focuses on developing, acquiring, and in-licensing specialized renal medications, distributing these essential drugs and supplies to both individual patients' homes and dialysis centers.

The company also extends its medical offerings to include a variety of specialized services such as vascular, cardiovascular, and endovascular care, operating ambulatory surgery centers for vascular procedures, and providing physician services in nephrology and cardiology. Products are sold directly to dialysis clinics, hospitals, and specialized treatment centers, complemented by sales through local teams, independent distributors, dealers, and agents. By February 23, 2022, Fresenius Medical Care managed an impressive network of 4,171 outpatient dialysis clinics across roughly 150 countries. Established in 1996, the company maintains its headquarters in Bad Homburg, Germany.

Key Metrics
Market Cap$12.15B
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership8.69%

based on 519.02M shares outstanding

Sector--
Industry--
ExchangeNYSE
CountryDEDE
IPO DateSep 17, 1996
Shares Outstanding519.02M
Authorized Shares
Float532.21M
52-Week Range
$20.02$26.42
$23.40(53rd percentile)
Volume
Average Daily Volume1.39M
1.09M today vs 1.39M avg(-22%)

30d Avg

1.39M

60d Avg

1.14M

90d Avg

966.99K

Earnings
Dividend History
TTM Yield
3.69%
Paid annually
Annual (LTM)
$0.86
Latest
$0.8643
May 22, 26
5Y Growth
+0.72%
per year
Compliance Status
Loading compliance data...